학술논문
Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study)
Document Type
Original Paper
Author
Ziadé, Nelly; Abbas, Noura; Hmamouchi, Ihsane; El Kibbi, Lina; Maroof, Avin; Elzorkany, Bassel; Abdulateef, Nizar; Adnan, Asal; Ihsan Awadh, Nabaa; Gorial, Faiq Isho; Alchama, Nada; Haouichat, Chafika; Alnaimat, Fatima; Hannawi, Suad; Atawnah, Saed; Halabi, Hussein; Al Mashaleh, Manal; Aljazwi, Laila; Abogamal, Ahmed; Ayoub, Laila; Bouajina, Elyes; Bahiri, Rachid; Saad, Sahar; Sabkar, Maha; Aouad, Krystel; Gossec, Laure
Source
Rheumatology International: Clinical and Experimental Investigations. 44(5):885-899
Subject
Language
English
ISSN
1437-160X
Abstract
The Psoriatic Arthritis Impact of Disease (PsAID-12) questionnaire, a recommended measure of patient-reported impact for psoriatic arthritis (PsA), was initially developed in Europe and may lack universal validity. Recognizing the need for a culturally appropriate tool for Arab patients, this study aimed to TranslAte, CulTurally adapt, and validate the PsAID in ArabIC (TACTIC). The PsAID-12 was translated into Arabic using a rigorous process of double translation, back-translation, and cognitive debriefing. The Arabic version was then validated through a study conducted in 13 Arab countries in 2022. Participants were consecutive literate adult patients diagnosed with PsA and fulfilling the CASPAR criteria. Collected data included PsAID-12, disease activity, and legacy patient-reported outcomes. Psychometric properties, such as internal consistency, construct validity, and test–retest reliability, were examined. Factors associated with high PsAID-12 total scores (> 4) were explored using multivariable binary logistic regression. A culturally adapted Arabic PsAID-12 questionnaire was achieved with minor rephrasing. The validation study included 554 patients from 13 countries (mean age 45 years, 59% females), with a mean PsAID score of 3.86 (SD 2.33). The Arabic PsAID-12 demonstrated excellent internal consistency (Cronbach’s α = 0.95), and correlations with other measures ranged from 0.63 to 0.78. Test–retest reliability (N = 138 patients) was substantial (intraclass correlation coefficient, ICC 0.90 [0.86–0.93]; Cohen’s kappa 0.80). Factors associated with a high PsAID score were disability (odds ratio, OR 3.15 [2.03–4.89]), depression (OR 1.56 [1.35–1.81]), widespread pain (OR 1.31 [1.12–1.53]), and disease activity (OR 1.29 [1.13–1.47]). Pain and fatigue were identified as the most impactful PsAID-12 domains for PsA patients. The Arabic PsAID is a valid and reliable measure that reflects the priorities of patients with PsA. PsAID scores correlated with disease activity and legacy outcome measures, as expected, indicating PsAID is a consistent measure of PsA impact across cultures. These findings highlight the potential of the Arabic PsAID in improving the care provided to Arabic-speaking patients worldwide.